drugset / Trial / NCT04905342
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2.
Timeline
- Start
- 2021-08-14
- Primary completion
- 2021-12-20
- Completion
- 2022-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVP-1805 | Unknown | 10 mg | Oral |
| Subject | NVP-1805 | Unknown | 20.8 mg | Oral |
| Subject | NVP-1805 | Unknown | 80 mg | Oral |
| Comparator | NVP-1805-R1 | Unknown | 80 mg | Oral |
| Comparator | NVP-1805-R2 | Unknown | 10 mg | Oral |
| Comparator | NVP-1805-R2 | Unknown | 20.8 mg | Oral |
Indications
No indication recorded.